Cargando…
Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
Chile is among the most successful nations worldwide in terms of its COVID-19 vaccine rollout. By 31 December 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster doses using different COVID-19 vaccines. In this context, we aimed to estimate the prevalence of anti-SARS-CoV-...
Autores principales: | Aguilera, Ximena, González, Claudia, Apablaza, Mauricio, Rubilar, Paola, Icaza, Gloria, Ramírez-Santana, Muriel, Pérez, Claudia, Cortes, Lina Jimena, Núñez-Franz, Loreto, Quezada-Gaete, Rubén, Castillo-Laborde, Carla, Correa, Juan, Said, Macarena, Hormazábal, Juan, Vial, Cecilia, Vial, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322351/ https://www.ncbi.nlm.nih.gov/pubmed/35891166 http://dx.doi.org/10.3390/vaccines10071002 |
Ejemplares similares
-
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
por: Núñez-Franz, Loreto, et al.
Publicado: (2023) -
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
por: Aguilera, Ximena, et al.
Publicado: (2022) -
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile
por: Vial, Pablo, et al.
Publicado: (2022) -
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
por: Hormazábal, Juan, et al.
Publicado: (2023) -
First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate
por: Vial, Pablo A., et al.
Publicado: (2022)